Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-07

FDA Approved: DOXYCYCLINE — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a generic doxycycline product under an original new drug application by Par Health USA, LLC (ANDA216690).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

ORIG AP for DOXYCYCLINE (DOXYCYCLINE)